NO20074490L - Vandige gelformuleringer inneholdende -(2-metylpropyl)-1H-Imidazo [4,5-C][1,5]naftyridin-4-amin - Google Patents
Vandige gelformuleringer inneholdende -(2-metylpropyl)-1H-Imidazo [4,5-C][1,5]naftyridin-4-aminInfo
- Publication number
- NO20074490L NO20074490L NO20074490A NO20074490A NO20074490L NO 20074490 L NO20074490 L NO 20074490L NO 20074490 A NO20074490 A NO 20074490A NO 20074490 A NO20074490 A NO 20074490A NO 20074490 L NO20074490 L NO 20074490L
- Authority
- NO
- Norway
- Prior art keywords
- naphthyridin
- imidazo
- methylpropyl
- amine
- aqueous gel
- Prior art date
Links
- 238000009472 formulation Methods 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- UCPMSMNKGXUFCC-UHFFFAOYSA-N 1-(2-methylpropyl)imidazo[4,5-c][1,5]naphthyridin-4-amine Chemical compound C1=CC=NC2=C3N(CC(C)C)C=NC3=C(N)N=C21 UCPMSMNKGXUFCC-UHFFFAOYSA-N 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Inorganic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Virology (AREA)
- Immunology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US64993205P | 2005-02-04 | 2005-02-04 | |
| US69841605P | 2005-07-12 | 2005-07-12 | |
| PCT/US2006/003745 WO2006084073A2 (en) | 2005-02-04 | 2006-02-03 | Aqueous gel formulations containing 1-(2-methylpropyl)-1h-imidazo[4,5-c][1,5]naphthyridin-4-amine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20074490L true NO20074490L (no) | 2007-10-30 |
Family
ID=36777933
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20074490A NO20074490L (no) | 2005-02-04 | 2007-09-04 | Vandige gelformuleringer inneholdende -(2-metylpropyl)-1H-Imidazo [4,5-C][1,5]naftyridin-4-amin |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20080207675A1 (pt) |
| EP (1) | EP1845980A2 (pt) |
| JP (1) | JP2008530014A (pt) |
| KR (1) | KR20070102728A (pt) |
| AR (1) | AR053807A1 (pt) |
| AU (1) | AU2006210587A1 (pt) |
| BR (1) | BRPI0607109A2 (pt) |
| CA (1) | CA2596358A1 (pt) |
| IL (1) | IL184825A0 (pt) |
| MX (1) | MX2007009448A (pt) |
| NO (1) | NO20074490L (pt) |
| RU (1) | RU2007129248A (pt) |
| TW (1) | TW200638931A (pt) |
| WO (1) | WO2006084073A2 (pt) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT1791417E (pt) | 2004-08-18 | 2013-01-23 | Alellyx Sa | Polinucleótidos, construções de adn e métodos para a alteração do teor e/ou da composição de lenhina de plantas |
| US8436176B2 (en) * | 2004-12-30 | 2013-05-07 | Medicis Pharmaceutical Corporation | Process for preparing 2-methyl-1-(2-methylpropyl)-1H-imidazo[4,5-c][1,5]naphthyridin-4-amine |
| AU2006210392A1 (en) | 2005-02-04 | 2006-08-10 | Coley Pharmaceutical Group, Inc. | Aqueous gel formulations containing immune response modifiers |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL349773A1 (en) * | 1999-01-08 | 2002-09-09 | 3M Innovative Properties Co | Formulations comprising imiquimod or other immune response modifiers for treating mucosal conditions |
| IL161786A0 (en) * | 2001-11-29 | 2005-11-20 | 3M Innovative Properties Co | Pharmaceutical formulations comprising an immune |
-
2006
- 2006-02-03 BR BRPI0607109-0A patent/BRPI0607109A2/pt not_active IP Right Cessation
- 2006-02-03 JP JP2007554220A patent/JP2008530014A/ja not_active Abandoned
- 2006-02-03 AU AU2006210587A patent/AU2006210587A1/en not_active Abandoned
- 2006-02-03 KR KR1020077020117A patent/KR20070102728A/ko not_active Withdrawn
- 2006-02-03 MX MX2007009448A patent/MX2007009448A/es not_active Application Discontinuation
- 2006-02-03 EP EP06720178A patent/EP1845980A2/en not_active Withdrawn
- 2006-02-03 WO PCT/US2006/003745 patent/WO2006084073A2/en not_active Ceased
- 2006-02-03 RU RU2007129248/15A patent/RU2007129248A/ru not_active Application Discontinuation
- 2006-02-03 AR ARP060100407A patent/AR053807A1/es not_active Application Discontinuation
- 2006-02-03 TW TW095103863A patent/TW200638931A/zh unknown
- 2006-02-03 CA CA002596358A patent/CA2596358A1/en not_active Abandoned
- 2006-02-03 US US11/815,491 patent/US20080207675A1/en not_active Abandoned
-
2007
- 2007-07-25 IL IL184825A patent/IL184825A0/en unknown
- 2007-09-04 NO NO20074490A patent/NO20074490L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| TW200638931A (en) | 2006-11-16 |
| AU2006210587A1 (en) | 2006-08-10 |
| RU2007129248A (ru) | 2009-03-10 |
| EP1845980A2 (en) | 2007-10-24 |
| US20080207675A1 (en) | 2008-08-28 |
| BRPI0607109A2 (pt) | 2009-08-04 |
| IL184825A0 (en) | 2007-12-03 |
| CA2596358A1 (en) | 2006-08-10 |
| KR20070102728A (ko) | 2007-10-19 |
| AR053807A1 (es) | 2007-05-23 |
| WO2006084073A2 (en) | 2006-08-10 |
| WO2006084073A3 (en) | 2007-06-28 |
| JP2008530014A (ja) | 2008-08-07 |
| MX2007009448A (es) | 2008-03-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP20027480A (es) | Indolil alquil amino derivados sustituidos como nuevos inhibidores de la histona desacetilasa | |
| CL2007002095A1 (es) | Composicion farmaceutica topica que comprende 1-(2-metilpropil)-1h-imidazo[4,5-c]quinolin-4-amina; composicion empacada; metodo para esterilizarla; util para cicatrizar tejido donde la dermis se ha desgarrado. | |
| UY30942A1 (es) | Nuevos derivados de 3-([1,2,4,]triazolo[4,3-a]piridin-7-il)benzamida | |
| AR052447A1 (es) | Etansulfonato de 1-(2-metipropil)-1h-imidazo[4,5-c] [1,5] naftiridin-4- amina y metansulfonato de 1-(2- metipropil)-1h-imidazo[4,5 -c] [1,5] naftiridin-4-amina | |
| CY1109916T1 (el) | Βενζιμιδαζολο-θειοφαινικες ενωσεις ως plk αναστολεις | |
| CY1109722T1 (el) | Ενδιαμεσες ενωσεις για την παρασκευη της trans-5-chloro-2-methyl-2,3,3a,12b-tetrahydro-1h-dibenz[2,3:6,73oxepino[4,5-c]pyrrole | |
| PA8570901A1 (es) | Derivados de acil-4-carboxifenilurea, procedimientos para su preparacion y su uso | |
| NO20081878L (no) | Diacylindazolderivater som lipase- og fosfolipaseinhibitorer | |
| CR9851A (es) | Derivados de triazolopiridina en calidad de inhibidores de lipasas y fosfolipasas | |
| CR9217A (es) | Proceso para preparacion de 2-metil-1(2-metilpropil)-1h-imidazo (4,5c)(1,5) naftiridina-4-amino | |
| DOP2010000304A (es) | Composiciones y metodos de preparacion y uso de las mismas | |
| UY29781A1 (es) | Compuestos diazaspiro sustituidos, sales farmacéuticamente aceptables, composiciones farmacéuticas que contienen los compuestos o sales, métodos de preparación y usos | |
| ECSP088558A (es) | Carbonilamino pirrolopirazoles, potentes inhibidores de quinasa | |
| NO20090294L (no) | Spirocykliske azaindolderivater | |
| EA201170227A1 (ru) | Имидазолкарбоксамиды | |
| NO20070785L (no) | Sammensetninger for levering av svaert vannloselige medikamenter. | |
| ECSP088203A (es) | Dispersiones amorfas sólidas | |
| ITMI20031570A1 (it) | Composizione per uso dietetico, farmaceutico o cosmetico | |
| MX2007006558A (es) | Formulaciones topicas de nepafenac. | |
| ATE495730T1 (de) | Alkaloid-formulierungen | |
| CL2008002082A1 (es) | Compuestos derivados de 6-fenil-1h-imidazo[4,5-c]piridina-4-carbonitrilo, inhibidores de catepsina s y catepsina k; composicion farmaceutica; y uso en el tratamiento de osteoporosis, aterosclerosis, inflamacion, entre otras enfermedades. | |
| CY1117174T1 (el) | ΧΡΗΣΗ 24-norUDCA ΓΙΑ ΤΗΝ ΑΓΩΓΗ ΧΟΛΟΣΤΑΤΙΚΩΝ ΝΟΣΗΜΑΤΩΝ ΤΟΥ ΗΠΑΤΟΣ | |
| WO2009032843A3 (en) | Deuterated ethambutols and their use | |
| NO20080035L (no) | Benzooksazol-2-on derivater som lipase og fosfolipaseinhibitorer | |
| DK1771155T3 (da) | Fremgangsmåde og sammensætning til behandling af rhinitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |